| scholarly article | Q13442814 |
| P2093 | author name string | Long Wang | |
| Yuanyuan Xu | |||
| Guosheng Ren | |||
| Ziying Yi | |||
| Yushen Wu | |||
| Yanxin Su | |||
| Huimin Du | |||
| Fachun Zhou | |||
| Bailin Niu | |||
| P2860 | cites work | Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression | Q38836832 |
| The immune system's role in sepsis progression, resolution, and long-term outcome | Q38991057 | ||
| Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit | Q39004033 | ||
| LAG3 (CD223) as a cancer immunotherapy target | Q39160974 | ||
| Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle | Q39588896 | ||
| Recognizing Sepsis as a Global Health Priority - A WHO Resolution | Q40154811 | ||
| Anti-PD-L1 peptide improves survival in sepsis | Q40404109 | ||
| Expression of PD-1/LAG-3 and cytokine production by CD4(+) T cells during infection with Plasmodium parasites | Q40860198 | ||
| LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes. | Q41703479 | ||
| Variant surface glycoprotein density defines an immune evasion threshold for African trypanosomes undergoing antigenic variation | Q42265330 | ||
| LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors | Q42517038 | ||
| Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis | Q44218744 | ||
| Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia | Q50028314 | ||
| Temporal Trends in Incidence, Sepsis-Related Mortality, and Hospital-Based Acute Care After Sepsis. | Q51748463 | ||
| Lymphocyte-activation gene-3, an important immune checkpoint in cancer | Q26746209 | ||
| The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 | ||
| The pathophysiology and treatment of sepsis | Q29619103 | ||
| Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 | ||
| Role of circulating lymphocytes in patients with sepsis | Q34177314 | ||
| Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape | Q34241893 | ||
| PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice | Q34577678 | ||
| Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells | Q34856800 | ||
| Immunosuppression in patients who die of sepsis and multiple organ failure | Q35991015 | ||
| A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis | Q36633756 | ||
| Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses | Q36684521 | ||
| Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3. | Q36925537 | ||
| Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis | Q36997987 | ||
| Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach | Q37233354 | ||
| Clinical blockade of PD1 and LAG3--potential mechanisms of action | Q38298241 | ||
| Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. | Q38433744 | ||
| Basics of PD-1 in self-tolerance, infection, and cancer immunity | Q38728635 | ||
| Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection. | Q52608541 | ||
| Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells. | Q52657140 | ||
| Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. | Q53238938 | ||
| SnapShot: T Cell Exhaustion. | Q53286739 | ||
| Lymphocyte-activation gene 3(+) (LAG3(+)) forkhead box protein 3(-) (FOXP3(-)) regulatory T cells induced by B cells alleviates joint inflammation in collagen-induced arthritis. | Q53795959 | ||
| Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer. | Q55250324 | ||
| Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection. | Q55347066 | ||
| Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer. | Q55391924 | ||
| Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression | Q57050465 | ||
| Precision Immunotherapy for Sepsis | Q57160595 | ||
| Focus on sepsis: new concepts and findings in sepsis care | Q57284229 | ||
| Oxygen Saturation on Admission Is a Predictive Biomarker for PD-L1 Expression on Circulating Monocytes and Impaired Immune Response in Patients With Sepsis | Q58764867 | ||
| Programmed Cell Death-1/Programmed Death-Ligand 1 Blockade Improves Survival of Animals with Sepsis: A Systematic Review and Meta-Analysis | Q58787789 | ||
| Drug response to PD-1/PD-L1 blockade: based on biomarkers | Q58795673 | ||
| T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses | Q59341026 | ||
| Roles, function and relevance of LAG3 in HIV infection | Q61814824 | ||
| Formalization of the MESF unit of fluorescence intensity | Q75208988 | ||
| Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis | Q84255932 | ||
| Sepsis and septic shock | Q89222248 | ||
| Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 | Q90726576 | ||
| Peripheral PD-1+ T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection | Q91971774 | ||
| Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function | Q93062525 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | sepsis | Q183134 |
| T cell exhaustion | Q56649209 | ||
| P304 | page(s) | 1888 | |
| P577 | publication date | 2019-08-07 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint Blockade | |
| P478 | volume | 10 |
| Q91711995 | The Role of PD-1 in Acute and Chronic Infection | cites work | P2860 |
Search more.